These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cytophagic histiocytic panniculitis improved by combined CHOP and cyclosporin A treatment. Ito M; Ohira H; Miyata M; Suzuki T; Sato Y; Kaise S; Nishimaki T; Sakuma H; Nihei Y; Iwatsuki K; Kasukawa R Intern Med; 1999 Mar; 38(3):296-301. PubMed ID: 10337947 [TBL] [Abstract][Full Text] [Related]
6. [Cytophagic histiocytic panniculitis]. Shi J; Liu HR; Fang K Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):59-60. PubMed ID: 15796888 [No Abstract] [Full Text] [Related]
7. Cytophagic histiocytic panniculitis: a report of four cases. Pettersson T; Kariniemi AL; Tervonen S; Franssila K Br J Dermatol; 1992 Dec; 127(6):635-40. PubMed ID: 1282361 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous Panniculitis-like T Cell Lymphoma Diagnosed with a Slowly Progressive Course: A Case Report. Kawamura H; Koike T; Shibata M; Kaneko R; Fujita S; Akiyama K; Toyama D; Yamada Y; Uchiyama A; Yamamoto S Tokai J Exp Clin Med; 2024 Jul; 49(2):48-52. PubMed ID: 38904233 [TBL] [Abstract][Full Text] [Related]
9. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis. Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251 [TBL] [Abstract][Full Text] [Related]
10. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission]. Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049 [TBL] [Abstract][Full Text] [Related]
11. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma. Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B; Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635 [TBL] [Abstract][Full Text] [Related]
17. Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. Bartlett NL; Petroni GR; Parker BA; Wagner ND; Gockerman JP; Omura GA; Canellos GP; Robert M; Johnson JL; Peterson BA Cancer; 2001 Jul; 92(2):207-17. PubMed ID: 11466671 [TBL] [Abstract][Full Text] [Related]
18. Cytophagic histiocytic panniculitis. Case report with resolution after treatment. Alegre VA; Fortea JM; Camps C; Aliaga A J Am Acad Dermatol; 1989 May; 20(5 Pt 2):875-8. PubMed ID: 2715442 [TBL] [Abstract][Full Text] [Related]
19. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma]. Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532 [No Abstract] [Full Text] [Related]
20. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma. Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508 [No Abstract] [Full Text] [Related] [Next] [New Search]